Paper28126304
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
Doll CM and 18 others. Int J Radiat Oncol Biol Phys, 2017. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811. Papers, record 28126304. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28126304
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Anus Neoplasms | Major topic |
| Chemoradiotherapy | Major topic |
| ErbB Receptors | Major topic |
| Ki-67 Antigen | Major topic |
| Neoplasm Proteins | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Cisplatin | |
| Female | |
| Fluorouracil | |
| Humans | |
| Male | |
| Middle Aged | |
| Mitomycin | |
| Prognosis | |
| Sex Factors | |
| Treatment Failure | |
| Treatment Outcome |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U10 CA180868 | NCI NIH HHS | United States | U10CA180868 | PubMed and NIH | NIH RePORTER |
| UG1 CA189867 | NCI NIH HHS | United States | UG1CA189867 | PubMed and NIH | NIH RePORTER |
| U10 CA037422 | NCI NIH HHS | United States | U10CA037422 | PubMed | NIH RePORTER |
| U10 CA021661 | NCI NIH HHS | United States | U10CA021661 | PubMed | NIH RePORTER |
| U10 CA180822 | NCI NIH HHS | United States | U10CA180822 | PubMed and NIH | NIH RePORTER |
| U24 CA114734 | NCI NIH HHS | United States | U24CA114734 | PubMed | NIH RePORTER |
| U24 CA180803 | NCI NIH HHS | United States | U24CA180803 | PubMed | NIH RePORTER |
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17000658 | The epidermal growth factor receptor pathway: a model for targeted therapy. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17000658 | PubMed |
| 2 | 15578079 | Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death. | Mod Pathol | 2005 | https://conductscience.org/library/papers/15578079 | PubMed |
| 3 | 8874455 | Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. | Lancet | 1996 | https://conductscience.org/library/papers/8874455 | PubMed |
| 4 | 10888772 | Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. | Arch Pathol Lab Med | 2000 | https://conductscience.org/library/papers/10888772 | PubMed |
| 5 | 24662454 | Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancer. | J Thorac Oncol | 2014 | https://conductscience.org/library/papers/24662454 | PubMed |
| 6 | 18430910 | Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. | JAMA | 2008 | https://conductscience.org/library/papers/18430910 | PubMed |
| 7 | 24127500 | The increasing incidence of anal cancer: can it be explained by trends in risk groups? | Neth J Med | 2013 | https://conductscience.org/library/papers/24127500 | PubMed |
| 8 | 27052656 | Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes. | Ann Oncol | 2016 | https://conductscience.org/library/papers/27052656 | PubMed |
| 9 | 24035327 | Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial. | Int J Radiat Oncol Biol Phys | 2013 | https://conductscience.org/library/papers/24035327 | PubMed |
| 10 | 24642661 | KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC). | PLoS One | 2014 | https://conductscience.org/library/papers/24642661 | PubMed |
| 11 | 24595598 | EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab. | J Cancer Res Clin Oncol | 2014 | https://conductscience.org/library/papers/24595598 | PubMed |
| 12 | 25042878 | EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324. | Radiother Oncol | 2014 | https://conductscience.org/library/papers/25042878 | PubMed |
| 13 | 20152769 | Ki67 in breast cancer: prognostic and predictive potential. | Lancet Oncol | 2010 | https://conductscience.org/library/papers/20152769 | PubMed |
| 14 | 23150707 | Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/23150707 | PubMed |
| 15 | 24021343 | p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy. | Radiother Oncol | 2013 | https://conductscience.org/library/papers/24021343 | PubMed |
| 16 | 12389040 | Automated subcellular localization and quantification of protein expression in tissue microarrays. | Nat Med | 2002 | https://conductscience.org/library/papers/12389040 | PubMed |
| 17 | 19923868 | Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status. | Oncology | 2009 | https://conductscience.org/library/papers/19923868 | PubMed |
| 18 | 22949905 | Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer. | Case Rep Oncol | 2012 | https://conductscience.org/library/papers/22949905 | PubMed |
| 19 | 23755922 | Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy. | Int J Radiat Oncol Biol Phys | 2013 | https://conductscience.org/library/papers/23755922 | PubMed |
| 20 | 1683905 | A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. | J Pathol | 1991 | https://conductscience.org/library/papers/1683905 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40360682 | Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer. | Nat Rev Clin Oncol | 2025 | https://conductscience.org/library/papers/40360682 | PubMed |
| 36009576 | Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009576 | PubMed |
| 33801992 | Evolution of the Role of Radiotherapy for Anal Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33801992 | PubMed |
| 32864041 | Prognostic role of ultrasonography staging in patients with anal cancer. | World J Gastrointest Oncol | 2020 | https://conductscience.org/library/papers/32864041 | PubMed |
| 31288054 | Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer. | Int J Radiat Oncol Biol Phys | 2019 | https://conductscience.org/library/papers/31288054 | PubMed |
| 29931433 | Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma. | Mol Imaging Biol | 2019 | https://conductscience.org/library/papers/29931433 | PubMed |
| 29719621 | Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study. | Oncotarget | 2018 | https://conductscience.org/library/papers/29719621 | PubMed |
| 28409247 | [Cetuximab plus chemoradiotherapy for anal carcinoma in immunocompetent patients does not change existing therapy standards : Results from the prospective, multicenter E3205 trial]. | Strahlenther Onkol | 2017 | https://conductscience.org/library/papers/28409247 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADA2 | 51816 | PubTator's text mining | https://conductscience.org/library/genes/51816 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28126304
GET https://conductscience.org/api/papers/v1/28126304/references?page=2